HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Christopher D Willey Selected Research

matrigel

8/2010Enzastaurin (LY317615), a protein kinase C beta selective inhibitor, enhances antiangiogenic effect of radiation.
5/2007Inhibition of poly(ADP-ribose) polymerase enhances cell death and improves tumor growth delay in irradiated lung cancer models.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Christopher D Willey Research Topics

Disease

48Neoplasms (Cancer)
06/2022 - 04/2007
13Glioblastoma (Glioblastoma Multiforme)
01/2022 - 01/2012
9Lung Neoplasms (Lung Cancer)
01/2021 - 05/2007
8Head and Neck Neoplasms (Head and Neck Cancer)
01/2022 - 04/2007
6Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2020 - 09/2009
4Brain Neoplasms (Brain Tumor)
01/2021 - 10/2017
3Neuroblastoma
06/2022 - 06/2021
3IGA Glomerulonephritis (IGA Nephropathy)
05/2020 - 01/2014
3Carcinoma (Carcinomatosis)
01/2020 - 05/2015
3Squamous Cell Carcinoma of Head and Neck
01/2020 - 06/2011
3Renal Cell Carcinoma (Grawitz Tumor)
04/2017 - 03/2014
2Breast Neoplasms (Breast Cancer)
01/2021 - 04/2019
2Neoplasm Metastasis (Metastasis)
04/2019 - 04/2017
2Carcinogenesis
03/2017 - 05/2016
2Hypertrophy
06/2008 - 10/2006
1Rectal Neoplasms (Rectal Cancer)
01/2022
1Kidney Diseases (Kidney Disease)
11/2021
1Residual Neoplasm
01/2021
1Melanoma (Melanoma, Malignant)
01/2021
1Deglutition Disorders (Dysphagia)
01/2021
1Pain (Aches)
01/2021
1Radiation Pneumonitis
01/2021
1Hepatoblastoma
01/2021
1Inflammation (Inflammations)
05/2020
1Urinary Bladder Neoplasms (Bladder Cancer)
01/2020
1Body Weight (Weight, Body)
01/2020
1Colorectal Neoplasms (Colorectal Cancer)
10/2019
1Wilms Tumor (Wilm's Tumor)
09/2019

Drug/Important Bio-Agent (IBA)

16Phosphotransferases (Kinase)IBA
01/2020 - 06/2008
11Proteins (Proteins, Gene)FDA Link
06/2022 - 10/2006
7Pharmaceutical PreparationsIBA
01/2022 - 05/2007
7Peptides (Polypeptides)IBA
11/2020 - 06/2008
5Myristoylated Alanine-Rich C Kinase SubstrateIBA
11/2020 - 06/2012
5Cetuximab (Erbitux)FDA Link
01/2020 - 06/2009
4ErbB Receptors (EGF Receptor)IBA
01/2022 - 06/2009
4DNA (Deoxyribonucleic Acid)IBA
01/2022 - 05/2007
3Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA
06/2022 - 03/2017
3Small Interfering RNA (siRNA)IBA
06/2021 - 09/2009
3Biological ProductsIBA
01/2021 - 01/2014
3Cisplatin (Platino)FDA LinkGeneric
01/2021 - 10/2011
3Biomarkers (Surrogate Marker)IBA
10/2020 - 01/2014
3galactosyl-deficient IgA1IBA
05/2020 - 01/2014
3Tyrosine (L-Tyrosine)FDA Link
04/2017 - 06/2008
2Focal Adhesion Protein-Tyrosine KinasesIBA
06/2022 - 09/2019
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2022 - 03/2014
2Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA
01/2021 - 03/2014
2SteroidsIBA
01/2021 - 12/2014
2LigandsIBA
01/2021 - 01/2020
2Phospholipids (Phosphatides)FDA LinkGeneric
11/2020 - 06/2019
2Temozolomide (Temodar)FDA LinkGeneric
11/2020 - 06/2014
2AutoantigensIBA
05/2020 - 11/2017
2Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
01/2020 - 09/2019
2Transcription Factors (Transcription Factor)IBA
10/2019 - 07/2015
2tyrosine receptor (receptor, tyrosine)IBA
06/2019 - 03/2015
2Immunoglobulin A (IgA)IBA
11/2017 - 01/2014
2matrigelIBA
08/2010 - 05/2007
16- (4- (3- (methylsulfonyl)benzylamino)- 5- (trifluoromethyl)pyrimidin- 2- ylamino)- 3,4- dihydroquinolin- 2(1H)- oneIBA
06/2022
1muconomycin AIBA
01/2022
1peposertibIBA
01/2022
1Fluorouracil (Carac)FDA LinkGeneric
01/2022
1Platelet-Derived Growth FactorIBA
11/2021
1Strap proteinIBA
06/2021
1Ado-Trastuzumab EmtansineIBA
01/2021
1Trastuzumab (Herceptin)FDA Link
01/2021
1Immune Checkpoint InhibitorsIBA
01/2021
1IpilimumabIBA
01/2021
1AZD1208IBA
01/2021
1LipidsIBA
01/2021
1Oxycodone (Oxycontin)FDA LinkGeneric
01/2021
1proto-oncogene proteins pimIBA
01/2021
1Cadherins (E-Cadherin)IBA
01/2021
1Programmed Cell Death 1 ReceptorIBA
01/2021
1Phosphatidylinositols (Phosphatidylinositol)IBA
11/2020
1Leukemia Inhibitory FactorIBA
05/2020
1Antigen-Antibody Complex (Immune Complex)IBA
05/2020
1CytokinesIBA
05/2020
1AutoantibodiesIBA
05/2020
1InterleukinsIBA
05/2020
1Oncostatin MIBA
05/2020
18- dibenzothiophen- 4- yl- 2- morpholin- 4- yl- chromen- 4- oneIBA
01/2020
1Epidermal Growth Factor (EGF)IBA
01/2020
1olaparibIBA
01/2020
1thiaclopridIBA
11/2019
1Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA
09/2019
1TensinsIBA
06/2019
1Phosphoric Monoester Hydrolases (Phosphatases)IBA
06/2019
1Syk KinaseIBA
04/2019
1fostamatinibIBA
04/2019
1SialyltransferasesIBA
02/2018

Therapy/Procedure

23Therapeutics
02/2022 - 05/2009
11Radiotherapy
01/2022 - 04/2007
4Drug Therapy (Chemotherapy)
01/2021 - 01/2018
2Aftercare (After-Treatment)
01/2022 - 09/2009
1Oncolytic Virotherapy
02/2022
1Neoadjuvant Therapy
01/2022
1Analgesia
01/2021
1Gastrostomy
01/2021
1Microspheres (Microsphere)
01/2021
1Artificial Respiration (Mechanical Ventilation)
01/2021
1Pain Management
01/2021